Literature DB >> 32451325

Prioritisation and the initiation of HCC surveillance in CHB patients: lessons to learn from the COVID-19 crisis.

Georgia Zeng1, Upkar S Gill2, Patrick T F Kennedy3.   

Abstract

Entities:  

Keywords:  hepatitis B; hepatocellular carcinoma; surveillance

Mesh：

Year:  2020        PMID： 32451325      PMCID： PMC7295856          DOI： 10.1136/gutjnl-2020-321627

Source DB:  PubMed          Journal:  Gut        ISSN： 0017-5749            Impact factor:   23.059


× No keyword cloud information.
  8 in total

Review 1.  Circulating biomarkers in the diagnosis and management of hepatocellular carcinoma.

Authors:  Philip Johnson; Qing Zhou; Doan Y Dao; Y M Dennis Lo
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2022-06-08       Impact factor: 73.082

2.  The COVID-19 Pandemic Highlights Opportunities to Improve Hepatocellular Carcinoma Screening and Diagnosis in a National Health System.

Authors:  Nicole J Kim; Karine Rozenberg-Ben-Dror; David A Jacob; Kristin Berry; George N Ioannou
Journal:  Am J Gastroenterol       Date:  2022-04-01       Impact factor: 12.045

3.  Assessing efficacy of hepatocellular carcinoma prediction scores to prioritise hepatitis B surveillance in the COVID-19 era.

Authors:  Ricky Sinharay; Andrew J Grant; Lucy Rivett; Rebecca Blackwell; George Mells; William Gelson
Journal:  GastroHep       Date:  2021-02-24

Review 4.  Hepatocellular Carcinoma in Chronic Viral Hepatitis: Where Do We Stand?

Authors:  Francesco Paolo Russo; Alberto Zanetto; Elisa Pinto; Sara Battistella; Barbara Penzo; Patrizia Burra; Fabio Farinati
Journal:  Int J Mol Sci       Date:  2022-01-02       Impact factor: 5.923

Review 5.  Screening, Surveillance, and Management of Hepatocellular Carcinoma During the COVID-19 Pandemic: a Narrative Review.

Authors:  Sami Akbulut; Ibrahim Umar Garzali; Abdirahman Sakulen Hargura; Ali Aloun; Sezai Yilmaz
Journal:  J Gastrointest Cancer       Date:  2022-05-02

Review 6.  Impact of SARS-CoV-2 Pandemic on the Management of Patients with Hepatocellular Carcinoma.

Authors:  Maria Guarino; Valentina Cossiga; Mario Capasso; Chiara Mazzarelli; Filippo Pelizzaro; Rodolfo Sacco; Francesco Paolo Russo; Alessandro Vitale; Franco Trevisani; Giuseppe Cabibbo
Journal:  J Clin Med       Date:  2022-07-31       Impact factor: 4.964

7.  Clinical characterization and therapeutic targets of vitamin A in patients with hepatocholangiocarcinoma and coronavirus disease.

Authors:  Xiao Liang; Rui Zhou; Yu Li; Lu Yang; Min Su; Keng Po Lai
Journal:  Aging (Albany NY)       Date:  2021-06-27       Impact factor: 5.682

Review 8.  Screening for Hepatocellular Carcinoma in Patients with Hepatitis B.

Authors:  Yashasavi Sachar; Mayur Brahmania; Renumathy Dhanasekaran; Stephen E Congly
Journal:  Viruses       Date:  2021-07-08       Impact factor: 5.048
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.